GGrantIndex
Sort

40,608 grants matching prostate cancer

SPORE in Genitourinary Cancer

$2,549,962
Colin P Dinney · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA

SPORE IN PROSTATE CANCER

$2,549,885
Baylor College Of Medicine · P50 · FY2000 · CA

CARCINOGENIC SIGNIFICANCE OF HETERCYCLIC AMINES

$2,548,940
James S. Felton · University Of Calif-Lawrnc Lvrmr Nat Lab · P01 · FY2006 · CA

Investigating Correlates and Therapeutics of Fatigue

$2,547,872
Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2024 · NR

Hormone-Related Cancers

$2,546,989
Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA

Elucidating Loci Involved in Prostate Cancer Suceptibility

$2,539,039
Brian E Henderson · University Of Southern California · U19 · FY2011 · CA

Basic and Translational Research Center for Reducing Health Disparities

$2,536,906
Jesus Alexander Angulo · Hunter College · G12 · FY2013 · MD

EPIDEMIOLOGIC STUDIES OF DIET AND CANCER IN HAWAII

$2,536,542
University Of Hawaii At Manoa · P01 · FY2001 · CA

MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER

$2,534,953
Sloan-Kettering Institute For Cancer Res · P50 · FY2004 · CA

SPORE in Prostate Cancer

$2,534,537
Dana-Farber Cancer Institute · P50 · FY2004 · CA

SPORE IN PROSTATE CANCER

$2,532,522
William George Nelson · Johns Hopkins University · P50 · FY2007 · CA

Chromatin Structure and Gene Expression

$2,532,437
Gordon L Hager · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,532,382
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2020 · CA

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,532,382
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2021 · CA

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,532,378
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2025 · CA

DCTD Screening Technologies

$2,528,434
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA

Prostate Cancer Susceptibility: The ICPCG Study

$2,528,315
Johns Hopkins University · U01 · FY2004 · CA

Risk Factors for Breast Cancer in Younger Nurses

$2,526,236
Walter C. Willett · Harvard School Of Public Health · R01 · FY2012 · CA

Enhancement of Cancer Research at Clark Atlanta University

$2,526,202
Shafiq A Khan · Clark Atlanta University · U54 · FY2024 · MD

CARCINOGENIC SIGNIFICANCE OF HETERCYCLIC AMINES

$2,524,887
University Of Calif-Lawrnc Lvrmr Nat Lab · P01 · FY2003 · CA

PACIFIC NORTHWEST PROSTATE CANCER SPORE

$2,524,662
Fred Hutchinson Cancer Research Center · P50 · FY2004 · CA

PACIFIC NORTHWEST PROSTATE CANCER SPORE

$2,524,662
Fred Hutchinson Cancer Research Center · P50 · FY2003 · CA

PACIFIC NORTHWEST PROSTATE CANCER SPORE

$2,523,922
Paul H Lange · Fred Hutchinson Cancer Research Center · P50 · FY2006 · CA

Interplay of tumor genomic and immune characteristics and external drivers of health to improve cancer health outcomes

$2,520,895
Susan M Chang · University Of California, San Francisco · U54 · FY2025 · CA

S.P.O.R.E. in Prostate Cancer

$2,519,289
Kenneth J. Pienta · University Of Michigan At Ann Arbor · P50 · FY2007 · CA